Effects of a Rho-Kinase Inhibitor in Patients With Pulmonary Hypertension Due to Left Heart Disease

JACC Heart Fail. 2024 Feb;12(2):409-411. doi: 10.1016/j.jchf.2023.08.030. Epub 2023 Oct 25.

Authors

Masaki Ishiyama, Naoki Fujimoto, Shusuke Fukuoka, Taku Omori, Keishi Moriwaki, Yoshito Ogihara, Shiro Nakamori, Tairo Kurita, Ryuji Okamoto, Kaoru Dohi

PMID: 37897457
DOI: 10.1016/j.jchf.2023.08.030

No abstract available

Publication types

Letter

MeSH terms

Heart
Heart Diseases*
Heart Failure* / complications
Heart Failure* / drug therapy
Humans
Hypertension, Pulmonary* / drug therapy
Hypertension, Pulmonary* / etiology
Protein Kinase Inhibitors / pharmacology
Protein Kinase Inhibitors / therapeutic use
Pulmonary Artery
rho-Associated Kinases / pharmacology

Substances

rho-Associated Kinases
Protein Kinase Inhibitors